These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 26526972)

  • 1. Bringing CLARITY to the human brain: visualization of Lewy pathology in three dimensions.
    Liu AK; Hurry ME; Ng OT; DeFelice J; Lai HM; Pearce RK; Wong GT; Chang RC; Gentleman SM
    Neuropathol Appl Neurobiol; 2016 Oct; 42(6):573-87. PubMed ID: 26526972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D imaging in the postmortem human brain with CLARITY and CUBIC.
    Ando K; Laborde Q; Brion JP; Duyckaerts C
    Handb Clin Neurol; 2018; 150():303-317. PubMed ID: 29496149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIGAR inclusion pathology is specific for Lewy body diseases.
    López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
    Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-Synuclein and Lewy pathology in Parkinson's disease.
    Kalia LV; Kalia SK
    Curr Opin Neurol; 2015 Aug; 28(4):375-81. PubMed ID: 26110807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-layered structure shared between Lewy bodies and lewy neurites-three-dimensional reconstruction of triple-labeled sections.
    Kanazawa T; Uchihara T; Takahashi A; Nakamura A; Orimo S; Mizusawa H
    Brain Pathol; 2008 Jul; 18(3):415-22. PubMed ID: 18394008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STochastic Optical Reconstruction Microscopy (STORM) reveals the nanoscale organization of pathological aggregates in human brain.
    Codron P; Letournel F; Marty S; Renaud L; Bodin A; Duchesne M; Verny C; Lenaers G; Duyckaerts C; Julien JP; Cassereau J; Chevrollier A
    Neuropathol Appl Neurobiol; 2021 Feb; 47(1):127-142. PubMed ID: 32688444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delusions and visual hallucinations in a patient with Parkinson's disease with dementia showing pronounced Lewy body pathology in the nucleus basalis of Meynert.
    Sakai K; Ikeda T; Ishida C; Komai K; Yamada M
    Neuropathology; 2019 Aug; 39(4):319-323. PubMed ID: 31243794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimised tissue clearing minimises distortion and destruction during tissue delipidation.
    Lee K; Lai HM; Soerensen MH; Hui ES; Ma VW; Cho WC; Ho YS; Chang RC
    Neuropathol Appl Neurobiol; 2021 Apr; 47(3):441-453. PubMed ID: 33107057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease.
    Covell DJ; Robinson JL; Akhtar RS; Grossman M; Weintraub D; Bucklin HM; Pitkin RM; Riddle D; Yousef A; Trojanowski JQ; Lee VM
    Neuropathol Appl Neurobiol; 2017 Dec; 43(7):604-620. PubMed ID: 28386933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson's disease brain.
    Roberts RF; Wade-Martins R; Alegre-Abarrategui J
    Brain; 2015 Jun; 138(Pt 6):1642-57. PubMed ID: 25732184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal CA2 Lewy pathology is associated with cholinergic degeneration in Parkinson's disease with cognitive decline.
    Liu AKL; Chau TW; Lim EJ; Ahmed I; Chang RC; Kalaitzakis ME; Graeber MB; Gentleman SM; Pearce RKB
    Acta Neuropathol Commun; 2019 Apr; 7(1):61. PubMed ID: 31023342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review: Clinical, neuropathological and genetic features of Lewy body dementias.
    Hansen D; Ling H; Lashley T; Holton JL; Warner TT
    Neuropathol Appl Neurobiol; 2019 Dec; 45(7):635-654. PubMed ID: 30977926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lewy body-related alpha-synucleinopathy in the aged human brain.
    Jellinger KA
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Braak staging valid for all types of Parkinson's disease?
    Jellinger KA
    J Neural Transm (Vienna); 2019 Apr; 126(4):423-431. PubMed ID: 29943229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies.
    Schlossmacher MG; Frosch MP; Gai WP; Medina M; Sharma N; Forno L; Ochiishi T; Shimura H; Sharon R; Hattori N; Langston JW; Mizuno Y; Hyman BT; Selkoe DJ; Kosik KS
    Am J Pathol; 2002 May; 160(5):1655-67. PubMed ID: 12000718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silver staining method for demonstrating Lewy bodies in Parkinson's disease and argyrophilic oligodendrocytes in multiple system atrophy.
    Braak E; Braak H
    J Neurosci Methods; 1999 Feb; 87(1):111-5. PubMed ID: 10066000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simplified method to perform CLARITY imaging.
    Poguzhelskaya E; Artamonov D; Bolshakova A; Vlasova O; Bezprozvanny I
    Mol Neurodegener; 2014 May; 9():19. PubMed ID: 24885504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical clearing of small intestine for three-dimensional visualization of cellular proliferation within crypts.
    Kaufman JA; Castro MJ; Sandoval-Skeet N; Al-Nakkash L
    J Anat; 2018 Jan; 232(1):152-157. PubMed ID: 28967147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
    Spillantini MG; Goedert M
    Ann N Y Acad Sci; 2000; 920():16-27. PubMed ID: 11193145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathology of Lewy body disorders.
    Kövari E; Horvath J; Bouras C
    Brain Res Bull; 2009 Oct; 80(4-5):203-10. PubMed ID: 19576266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.